EO 14398-broad agency announcement (BAA) contract for modernizing outcome data for opioid use disorder (MOD-OUD)
Active Definitive Contract Awarded
- Contract number
- 75F40126C00158
- Awardee
-
Digital Medicine Society Inc. UEI JBCJDZJPPJ51
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $948,781
Award facts
- Opportunity
-
- FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Special Notice · FDABAA2600123 · Posted Nov 21, 2025
- Contract value 100% obligated
- $948,781.00 Current and potential, with all options
- Completion date 14% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 257 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02114, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $948,781 firm-fixed-price definitive contract to Digital Medicine Society Inc., a Boston-based nonprofit, for modernizing outcome data for opioid use disorder (MOD-OUD) on September 16, 2026. No set-aside was used. Place of performance is Boston, Massachusetts, and the ultimate completion date is December 30, 2027.
The award resulted from the FY26 FDA Broad Agency Announcement for Advanced Research and Development of Regulatory Science, a Special Notice posted November 21, 2025, and issued by FDA's Office of Acquisition and Grant Services within HHS. Amendments ran through January 16, 2026, and FDA held a virtual BAA day on January 20, 2026. The two-stage process required Stage One packages (checklist, concept paper, and full proposal) by February 24, 2026. The BAA targets research across three charge areas: modernizing development and evaluation of FDA-regulated products, strengthening post-market surveillance and labeling, and invigorating public health preparedness and response. Priority areas include new approach methodologies, advanced manufacturing, analytical and computational methods, biomarkers, clinical outcome assessments, and emerging technologies. Eligible offerors include private sector organizations, FFRDCs, and academic institutions, with small businesses strongly encouraged. The solicitation expressed a preference for cost-reimbursement contracts, and this award is firm fixed price. The work is classified under NAICS 541714 and PSC AJ11.
Quick answers
Who was awarded contract 75F40126C00158?
75F40126C00158 was awarded to Digital Medicine Society Inc. by Food and Drug Administration (Department of Health and Human Services) on September 16, 2026.
How much is contract 75F40126C00158 worth?
The government has obligated $948,781 on 75F40126C00158.
Was contract 75F40126C00158 competed?
The extent of competition for 75F40126C00158 was full and open competition. The government received 257 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award